BMP-2 and OP-1 exert direct and opposite effects on renal branching morphogenesis

American Journal of Physiology - Renal Physiology

Volumn 273, Issue 6 42-6, 1997, Pages

  Piscione, Tino D ^a   Yager, Thomas D ^a   Gupta, Indra R ^a   Grinfeld, Branko ^a   Pei, York ^b   Attisano, Liliana ^c   Wrana, Jeffrey L ^a   Rosenblum, Norman D ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bone morphogenetic protein 2; Bone morphogenetic protein 7; Inner medullary collecting duct; Osteogenic protein 1; Tubulogenesis

Indexed keywords

AGAROSE; BONE MORPHOGENETIC PROTEIN; GROWTH FACTOR; OSTEOGENIC PROTEIN 1; PROTEIN SERINE THREONINE KINASE; RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; EMBRYO; EXPLANT; KIDNEY COLLECTING TUBULE; MORPHOGENESIS; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031426998     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1997.273.6.f961     Document Type: Article

References (41)

1. Basler, K., T. Edlund, T. M. Jessell, and T. Yamada. Control of cell pattern in the neural tube: regulation of cell differentiation by dorsalin-1, a novel TGF-β family member. Cell 73: 687-702, 1993.
2. Bitgood, M. J., and A. M. McMahon. Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev. Biol. 172: 126-138, 1995.
3. Bottaro, D. P., S. J. Rubin, D. L. Faletto, A. M.-L. Chan, T. E. Kmiecik, G. F. Van de Woude, and S. A. Aaronson. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251: 802-804, 1991.
4. Cantley, L. G., E. J. G. Barros, M. Gandhi, M. Rauchman, and S. K. Nigam. Regulation of mitogenesis, motogenesis, and tubulogenesis by hepatocyte growth factor in renal collecting duct cells. Am. J. Physiol. 267 (Renal Fluid Electrolyte Physiol. 36): F271-F280, 1994.
5. Carcamo, J., F. M. B. Weis, F. Ventura, R. Wieser, J. L. Wrana, L. Attisano, and J. Massagué. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor β and activin. Mol. Cell. Biol. 14: 3810-3821, 1994.
6. Dewulf, N., K. Verschueren, O. Lonnoy, A. Morén, S. Grimsby, K. Vande Spiegle, K. Miyazono, D. Huylebroeck, and P. ten Dijke. Distinct spatial and temporal expression patterns of two type 1 receptors for bone morphogenetic proteins during mouse embryogenesis. Endocrinology 136: 2652-2663, 1995.
7. Dudley, A. T., K. M. Lyons, and E. J. Robertson. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev. 9: 2795-2807, 1995.
8. Dudley, A. T., and E. J. Robertson. Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7 deficient embryos. Dev. Dyn. 208: 349-362, 1997.
9. Franzen, P., P. ten Dijke, H. Ichijo, H. Yamashita, P. Schulz, C.-H. Heldin, and K. Miyazono. Cloning of a TGFβ type 1 receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell 75: 681-692, 1993.
10. Frolik, C. A., L. M. Wakefield, D. M. Smith, and M. B. Sporn. Characterization of a membrane receptor for transforming growth factor-β in normal rat kidney fibroblasts. J. Biol. Chem. 259: 10995-11000, 1984.
11. Green, J. B. A., H. V. New, and J. C. Smith. Responses of embryonic Xenopus cells to activin and FGF are separated by multiple dose thresholds and correspond to distinct axes of the mesoderm. Cell 71: 731-739, 1992.
12. Harland, R. M. The transforming growth factor β family and induction of the vertebrate mesoderm: bone morphogenetic proteins are ventral inducers. Proc. Natl. Acad. Sci. USA 91: 10243-10246, 1994.
13. Hayek, A., F. L. Culler, G. M. Beattie, A. D. Lopez, P. Cuevas, and A. Baird. An in vivo model for study of the angiogenic effects of basic fibroblast growth factor. Biochem. Biophys. Res. Commun. 147: 876-880, 1987.
14. Hogan, B. L. M. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10: 1580-1594, 1996.
15. Hoodless, P. A., T. Haerry, S. Abdollah, M. Stapleton, M. B. O'Connor, L. Attisano, and J. L. Wrana. MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85: 489-500, 1996.
16. Kingsley, D. M. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8: 133-146, 1994.
17. Letsou, A., K. Arora, J. L. Wrana, K. Simin, V. Twombly, J. Jamal, K. Staehling-Hampton, F. M. Hoffmann, W. M. Gelbart, J. Massagué, and M. B. O'Connor. Drosophila dpp signaling is mediated by the punt gene product: a dual ligand-binding type II receptor of the TGFβ receptor family. Cell 80: 899-908, 1995.
18. Liu, F., F. Ventura, J. Doody, and J. Massagué. Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model of the BMPs. Mol. Cell. Biol. 15: 3479-3486, 1995.
19. Luo, G., C. Hofmann, A. L. J. J. Bronckers, M. Sohocki, A. Bradley, and G. Karsenty. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev. 9: 2808-2820, 1995.
20. Massagué, J. Identification of receptors for type-β transforming growth factor. Methods Enzymol. 146: 174-195, 1987.
21. Mishina, Y. A., A. Susuki, N. Ueno, and R. R. Behringer. BMPr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev. 9: 3027-3037, 1995.
22. Näthke, I. S., C. L. Adams, P. Polakis, J. H. Sellin, and W. J. Nelson. The adenomatous polyposis coli tumour suppressor protein localizes to plasma membrane sites involved in active cell migration. J. Cell Biol. 134: 165-179, 1996.
23. Nobes, C. D., and A. Hall. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamillipodia and filopodia. Cell 81: 53-62, 1995.
24. Ozkaynak, E., P. N. Schnegelsberg, and H. Oppermann. Murine osteogenic protein (OP-1): high levels of mRNA in kidney. Biochem. Biophys. Res. Commun. 179: 116-123, 1991.
25. Pichel, J. G., L. Shen, H. Z. Sheng, A.-C. Granholm, D. J. A. Grinberg, E. J. Lee, S. P. Huang, M. Saarmas, B. J. Hoffer, H. Sariola, and H. Westphal. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382: 73-76, 1996.
26. Rauchman, M. I., S. K. Nigam, E. Delpire, and S. R. Gullans. An osmotically tolerant inner medullary collecting duct cell line from an SV40 transgenic mouse. Am. J. Physiol. 265 (Renal Fluid Electrolyte Physiol. 34): F416-F424, 1993.
27. Ritvos, O., T. Tuuri, M. Eramaa, K. Sainio, K. Hilden, L. Saxen, and S. F. Gilbert. Activin disrupts epithelial branching morphogenesis in developing glandular organs of the mouse. Mech. Dev. 50: 229-245, 1995.
28. Ruberte, E., T. Marty, D. Nellen, M. Affolter, and K. Basler. An absolute requirement for both the type II and type I receptors, punt and thick veins, for dpp signaling in vivo. Cell 80: 889-897, 1995.
29. Santos, O. F. P., and S. K. Nigam. HGF-induced tubulogenesis and branching of epithelial cells is modulated by extracellular matrix and TGF-β. Dev. Biol. 160: 293-302, 1993.
30. Saxen, L. Organogenesis of the Kidney. Cambridge: Cambridge University Press, 1987.
31. Schreiber, A. B., M. E. Winkler, and R. Derynk. Transforming growth factor-α: a more potent angiogenic mediator than epidermal growth factor. Science 232: 1250-1253, 1986.
32. Ten Dijke, P., H. Yamashita, H. Ichijo, P. Franzen, M. Laiho, K. Miyazono, and C.-H. Heldin. Characterization of type 1 receptors for transforming growth factor-β and activin. Science 264: 101-104, 1994.
33. Ten Dijke, P., H. Yamashita, T. K. Sampath, A. H. Reddi, M. Estevez, D. L. Riddle, H. Ichijo, C.-H. Heldin, and K. Miyazono. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 269: 16985-16988, 1994.
34. Vukicevic, S., J. B. Kopp, F. P. Luyten, and T. K. Sampath. Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7). Proc. Natl. Acad. Sci. USA 93: 9021-9026, 1996.
35. Vukicevic, S., V. Latin, P. Chen, R. Batorsky, A. H. Reddi, and T. K. Sampath. Localization of osteogenic protein-1 (bone morphogenetic protein-7) during human embryonic development: high affinity binding to basement membranes. Biochem. Biophys. Res. Commun. 198: 693-700, 1994.
36. Wrana, J. L., L. Attisano, J. Carcamo, A. Zentella, J. Doody, M. Laiho, X.-F. Wang, and J. Massagué. TGFβ signals through a heteromeric protein kinase receptor complex. Cell 71: 1003-1014, 1992.
37. Wrana, J. L., L. Attisano, R. Wieser, F. Ventura, and J. Massagué. Mechanism of activation of the TGF-β receptor. Nature 370: 341-347, 1994.
38. Wrana, J. L., H. Tran, L. Attisano, K. Arora, S. R. Childs, J. Massagué, and M. B. O'Connor. Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex. Mol. Cell. Biol. 14: 944-950, 1994.
39. Yamashita, H., P. ten Dijke, D. Huylebroeck, T. K. Sampath, M. Andries, J. C. Smith, C.-H. Heldin, and K. Miyazono. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J. Cell Biol. 130: 217-226, 1995.
40. Yeger, H., D. Forget, J. Alami, and B. R. Williams. Analysis of WT1 gene expression during mouse nephrogenesis in organ culture. In Vitro Cell. Dev. Biol. 32: 496-504, 1996.
41. Zou, H., and L. Niswander. Requirement for BMP signaling in interdigital apoptosis and scale formation. Science 272: 738-741, 1996.